Other
Postoperative Recovery
0
Pipeline Programs↗
8
Active Trials↗
1
Companies Involved↗
Postoperative Recovery is an early-stage landscape with 0 programs across 1 company. The most active players are Yangtze River Pharmaceutical Group Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
36
clinical trials
Completed20 · 56%
Unknown status6 · 17%
Recruiting3 · 8%
Not yet recruiting2 · 6%
Active, not recruiting2 · 6%
Terminated2 · 6%
Other1 · 3%
Clinical Trials
Trial Activity
36 trials
Comparison of the Effects of Moderate- and High-Dose Glucocorticoids on Postoperative Recovery
Not yet recruiting·—·N/A·NCT07469332·135 enrolled
The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery
Enrolling by invitation·FFirst Affiliated Hospital of Kunming Medical University·N/A·NCT07125573·120 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)